Dr. Christo is LIVE in the studio with Michelle Makoi from Clear Cut on I24. They discuss the FDA’s approval of a new class of drug for depression called Esketamine. This is an important breakthrough in the treatment of treatment-resistant depression.
Video Player
00:00
00:00